GMRE:NYE-Global Medical REIT Inc (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 10.16

Change

+0.02 (+0.20)%

Market Cap

N/A

Volume

1.25M

Analyst Target

USD 14.79
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-19 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

-2.28 (-1.79%)

USD 79.04B
VTR Ventas Inc

-2.01 (-3.13%)

USD 26.84B
DOC Healthpeak Properties Inc

-0.22 (-0.99%)

USD 15.67B
CTRE CareTrust REIT Inc.

-0.39 (-1.26%)

USD 4.79B
NHI National Health Investors Inc

-1.81 (-2.13%)

USD 3.63B
AHR American Healthcare REIT, Inc.

+0.88 (+3.59%)

USD 3.26B
LTC LTC Properties Inc

-0.81 (-2.17%)

USD 1.64B
UHT Universal Health Realty Income..

-0.23 (-0.50%)

USD 0.64B
CHCT Community Healthcare Trust Inc

-0.51 (-2.94%)

USD 0.46B
GMRE-PA Global Medical REIT Inc

+0.17 (+0.68%)

USD 0.41B

ETFs Containing GMRE

KBWY Invesco KBW Premium Yield.. 3.52 % 0.35 %

+0.12 (+0%)

USD 0.24B
SDEF 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.47% 14% F 16% F
Dividend Return 3.78% 36% F 69% C-
Total Return -4.68% 14% F 17% F
Trailing 12 Months  
Capital Gain 12.39% 36% F 45% F
Dividend Return 6.97% 50% F 81% B-
Total Return 19.36% 36% F 52% F
Trailing 5 Years  
Capital Gain -11.34% 54% F 30% F
Dividend Return 35.95% 100% F 89% A-
Total Return 24.61% 62% D 48% F
Average Annual (5 Year Horizon)  
Capital Gain -3.17% 43% F 23% F
Dividend Return 3.56% 43% F 43% F
Total Return 6.73% 79% B- 88% B+
Risk Return Profile  
Volatility (Standard Deviation) 25.10% 36% F 42% F
Risk Adjusted Return 14.18% 43% F 35% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.